McKesson Co. (NYSE:MCK) Shares Acquired by Metis Global Partners LLC

Metis Global Partners LLC grew its stake in shares of McKesson Co. (NYSE:MCK) by 2.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,772 shares of the company’s stock after acquiring an additional 132 shares during the period. Metis Global Partners LLC’s holdings in McKesson were worth $2,672,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. OFI Invest Asset Management acquired a new position in McKesson during the 3rd quarter worth $26,000. BKM Wealth Management LLC bought a new stake in shares of McKesson during the 4th quarter valued at about $31,000. WASHINGTON TRUST Co raised its stake in McKesson by 42.5% during the fourth quarter. WASHINGTON TRUST Co now owns 114 shares of the company’s stock worth $53,000 after acquiring an additional 34 shares during the period. Milestone Investment Advisors LLC bought a new position in McKesson in the third quarter worth about $61,000. Finally, Orion Capital Management LLC acquired a new position in McKesson in the third quarter valued at approximately $63,000. 85.07% of the stock is owned by institutional investors and hedge funds.

McKesson Trading Up 0.4 %

Shares of McKesson stock opened at $535.64 on Tuesday. McKesson Co. has a 52 week low of $364.08 and a 52 week high of $544.81. The company’s 50-day moving average price is $530.66 and its two-hundred day moving average price is $493.16. The stock has a market cap of $70.39 billion, a PE ratio of 24.17, a price-to-earnings-growth ratio of 1.41 and a beta of 0.45.

McKesson (NYSE:MCK) last announced its quarterly earnings data on Wednesday, February 7th. The company reported $7.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.05 by $0.69. The company had revenue of $80.90 billion for the quarter, compared to analysts’ expectations of $77.93 billion. McKesson had a net margin of 0.99% and a negative return on equity of 262.63%. The business’s revenue was up 14.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $6.90 EPS. On average, equities analysts predict that McKesson Co. will post 27.59 EPS for the current fiscal year.

McKesson Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, July 1st. Stockholders of record on Monday, June 3rd will be paid a $0.62 dividend. The ex-dividend date is Friday, May 31st. This represents a $2.48 annualized dividend and a dividend yield of 0.46%. McKesson’s dividend payout ratio is currently 11.24%.

Analyst Ratings Changes

Several analysts recently issued reports on the company. Morgan Stanley raised their price target on McKesson from $522.00 to $548.00 and gave the stock an “overweight” rating in a report on Monday, April 15th. Citigroup boosted their price target on shares of McKesson from $575.00 to $620.00 and gave the company a “buy” rating in a report on Tuesday, April 30th. SVB Leerink initiated coverage on shares of McKesson in a report on Monday, February 26th. They issued an “outperform” rating and a $600.00 price objective on the stock. UBS Group lifted their price objective on shares of McKesson from $575.00 to $620.00 and gave the company a “buy” rating in a research report on Wednesday, March 6th. Finally, Mizuho upped their target price on shares of McKesson from $450.00 to $505.00 and gave the stock a “neutral” rating in a research report on Friday, February 9th. Two analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $536.71.

Insider Transactions at McKesson

In other news, CEO Brian S. Tyler sold 3,473 shares of McKesson stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $524.55, for a total value of $1,821,762.15. Following the transaction, the chief executive officer now owns 43,445 shares of the company’s stock, valued at approximately $22,789,074.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other McKesson news, EVP Leann B. Smith sold 186 shares of McKesson stock in a transaction that occurred on Tuesday, February 13th. The shares were sold at an average price of $496.00, for a total value of $92,256.00. Following the completion of the sale, the executive vice president now directly owns 1,511 shares in the company, valued at $749,456. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Brian S. Tyler sold 3,473 shares of McKesson stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $524.55, for a total transaction of $1,821,762.15. Following the completion of the sale, the chief executive officer now owns 43,445 shares of the company’s stock, valued at $22,789,074.75. The disclosure for this sale can be found here. Corporate insiders own 0.21% of the company’s stock.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.